Mandate

Vinge advises owner in connection with sale of Kung Markatta

May 06, 2013

Vinge has advised Ekomodern F, W & E AB in connection with the sale of Kung Markatta AB to Priveq Investment Fund IV. The company’s current indirect owners, i.e. Peter Enberg, Stefan Wilhelmson and CEO Anders Dahlin, will retain significant shareholdings through a new holding company formed in conjunction with the acquisition.

Kung Markatta is a market leader in Sweden within the distribution and marketing of ecological and natural products. The company, which was established in Örebro in 1983, has expanded significantly since it was acquired in 2004 by Peter Enberg and his partners. In addition to its own well-renowned range of approximately 150 ecological products under the Kung Markatta trade mark, the company also markets a large portfolio of other brands such as, among others, Alpro, Rice Dream, Yogi Tea, and Green & Black’s.  The company’s turnover in 2012 was approximately SEK 200 million and it currently employs 30 people.

Vinge’s team consisted of partner Daniel Rosvall together with, among others, associates Kristian Ford, Markus Larsson and Maria Dahlin.     

Related

Vinge advises Axcel VI and Currentum in connection with the acquisition of Elprojekt Skandinavien

Vinge advises Axcel VI and the Currentum Group in connection with the acquisition of Elprojekt Skandinavien. The company provides complete electrical installations throughout Sweden, focusing on new construction of logistics properties, production facilities, residential buildings and office buildings. Elprojekt Skandinavien had a revenue of SEK 316 million in 2024.
June 23, 2025

Vinge advises Meribel Pharma Solutions

Vinge advises Meribel Pharma Solutions in connection with the sale of a production facility specialising in the manufacture of antibiotics to Apotek Produktion & Laboratorier AB ("APL").
June 23, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 232 million and restructuring of debt financing

Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue, through which Hansa raises gross proceeds of approx. SEK 232 million, and restructuring of debt financing. As part of such debt restructuring, Hansa has in conjunction with the directed share issue set-off debt corresponding to approximately USD 14.9 million of its total debt amount.
June 23, 2025